Jagsonpal Pharmaceuticals Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Jagsonpal Pharmaceuticals Limited Company Profile :

Jagsonpal Pharmaceuticals Limited is an Indian company engaged in the business of manufacturing of pharmaceuticals and intermediate drugs.

The Company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. It manufactures capsules, tablets and ampoules. It operates research and development, manufacturing, marketing and distribution facilities.

Company has operations in Russia, Brazil, the United States, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt and Vietnam.


Jagsonpal Pharmaceuticals ResultsBSE Code : 507789
NSE Symbol : JAGSNPHARM
ISIN No. : INE048B01027
Industry :  Pharmaceuticals
Face Value : Rs. 5.00


If you are an investor who has shares of Jagsonpal Pharmaceuticals or you are an stock market analyst then i am sure you might for Quarterly Results of Jagsonpal Pharmaceuticals.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Jagsonpal Pharmaceuticals. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Jagsonpal Pharmaceuticals.

Jagsonpal Pharmaceuticals Q1 Results 2016-17 :

Jagsonpal Pharmaceuticals will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Jagsonpal Pharmaceuticals will announce its Q2 FY 2016-17 Results in the month of October 2016.

Jagsonpal Pharmaceuticals will announce its Q3 FY 2016-17 Results in the month of January 2017.

Jagsonpal Pharmaceuticals will announce its Q4 FY 2016-17 Results in the month of April 2017.

Jagsonpal Pharmaceuticals will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Jagsonpal Pharmaceuticals Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 144.08
Other Income  0.06  –
Total Income-  144.15
Expenditure  -131.68
Interest  -5.30
Depreciation-  -3.09
PBT  4.08
Tax  -0.82
Net Profit-  3.25
Equity  13.10
EPS  –

Note : If you like this information about Jagsonpal Pharmaceuticals Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.